These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3191030)

  • 1. Relationship between the in vitro sensitivity to cytosine arabinoside of blast progenitors and the outcome of treatment in acute myeloblastic leukaemia patients.
    Nara N; Suzuki T; Nagata K; Yamashita Y; Murohashi I; Adachi Y
    Br J Haematol; 1988 Oct; 70(2):187-91. PubMed ID: 3191030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sensitivity to cytosine arabinoside of the blast progenitors of acute myeloblastic leukemia.
    Nara N; Curtis JE; Senn JS; Tritchler DL; McCulloch EA
    Blood; 1986 Mar; 67(3):762-9. PubMed ID: 3456247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the proliferative activity and sensitivity to cytosine arabinoside of leukemic blast progenitors in acute myeloblastic leukemia at diagnosis and in relapse.
    Nara N; Tohda S; Suzuki T; Nagata K; Tanikawa S; Imai Y; Tomiyama J; Shiina S
    Acta Haematol; 1992; 88(1):17-21. PubMed ID: 1414157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the blast self-renewal capacity in patients with acute myeloid leukemia.
    Nara N; Kurokawa H; Tanikawa S; Tomiyama J; Nagata K
    Cancer; 1994 Jan; 73(1):92-7. PubMed ID: 8275443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro growth patterns and drug sensitivities of leukemic blast progenitors among the subtypes of acute myelocytic leukemia.
    Nara N; Chen GJ; Murohashi I; Tohda S; Imai Y; Tomiyama J; Nagata K; Suzuki T; Tanikawa S; Shiina S
    Exp Hematol; 1992 Aug; 20(7):904-8. PubMed ID: 1628709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting in vitro effects for the combination of fludarabine, cytosine arabinoside (Ara-C) and granulocyte colony-stimulating factor (FLAG) compared with daunorubicin and Ara-C in P-glycoprotein-positive and P-glycoprotein-negative acute myeloblastic leukaemia.
    Higashi Y; Turzanski J; Pallis M; Russell NH
    Br J Haematol; 2000 Nov; 111(2):565-9. PubMed ID: 11122104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cell culture model for the treatment of acute myeloblastic leukemia with fludarabine and cytosine arabinoside.
    Rayappa C; McCulloch EA
    Leukemia; 1993 Jul; 7(7):992-9. PubMed ID: 8321050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of TNFalpha on the growth and sensitivity to cytosine arabinoside of blast progenitors in acute myelogenous leukemia with special reference to the role of NF-kappaB.
    Wu Z; Shen L; Inatomi Y; U M; Miyashita T; Toyama K; Miyauchi J
    Leuk Res; 2003 Nov; 27(11):1009-18. PubMed ID: 12859994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of busulfan, cytosine arabinoside and adriamycin on different maturation stages of normal human bone marrow cells.
    Tohda S; Nagata K; Suzuki T; Nara N
    Acta Haematol; 1990; 83(1):16-21. PubMed ID: 2105564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for paclitaxel in the combination chemotherapy of acute myeloblastic leukaemia: preclinical cell culture studies.
    Curtis JE; Minkin S; Minden MD; McCulloch EA
    Br J Haematol; 1996 Nov; 95(2):354-63. PubMed ID: 8904892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of recombinant human tumor necrosis factor on the self-renewal capacity of leukemia blast progenitors in acute myeloblastic leukemia.
    Nagata K; Tohda S; Suzuki T; Nara N
    Leukemia; 1989 Sep; 3(9):626-30. PubMed ID: 2761317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the lethal effects in culture of cytosine arabinoside and arabinofuranosyl-5-azacytosine acting on the blast cells fo acute myeloblastic leukemia.
    Yang GS; McCulloch EA
    Hematol Pathol; 1992; 6(3):125-30. PubMed ID: 1385380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effect of interferon-gamma and tumor necrosis factor-alpha causing suppression of leukemic blast progenitors in acute myeloblastic leukemia.
    Nara N
    Leuk Lymphoma; 1993 Jun; 10(3):201-7. PubMed ID: 7693101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity to 5-azacytidine of blast progenitors in acute myeloblastic leukemia.
    Wang C; McCulloch EA
    Blood; 1987 Feb; 69(2):553-9. PubMed ID: 2432971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside.
    Yang GS; Minden MD; McCulloch EA
    Leukemia; 1993 Jul; 7(7):1012-9. PubMed ID: 7686602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of melphalan against self-renewal capacity of leukemic progenitors in acute myeloblastic leukemia.
    Demur C; Chiron M; Saivin S; Attal M; Dastugue N; Bousquet C; Galinier JL; Colombies P; Laurent G
    Leukemia; 1992 Mar; 6(3):204-8. PubMed ID: 1564957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity of 4-hydroperoxycyclophosphamide for the blast progenitors of acute myeloblastic leukemia.
    Nara N; Suzuki T; Yamashita Y; Murohashi I; Aoki N
    Cancer Res; 1988 May; 48(9):2348-52. PubMed ID: 3162711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to 5-azacytidine of leukemic blast cells in suspension: a biological parameter associated with response to chemotherapy.
    Wang C; Curtis JE; Senn JS; Tritchler DL; McCulloch EA
    Leukemia; 1987 Nov; 1(11):753-6. PubMed ID: 2446086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the in vitro growth of blast progenitors from acute myeloblastic leukemia patients by transforming growth factor-beta (TGF-beta).
    Nara N; Tohda S; Nagata K; Suzuki T; Yamashita Y
    Leukemia; 1989 Aug; 3(8):572-7. PubMed ID: 2473359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of platelet-derived growth factor on the proliferation of blast progenitors from acute myeloblastic leukemia patients.
    Nara N; Tohda S; Nagata K; Suzuki T; Yamashita Y; Imai Y
    Acta Haematol; 1990; 83(4):187-92. PubMed ID: 2115715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.